The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we ...

If you doubt Robert F. Kennedy Jr.'s leadership of HHS would be catastrophic to public health, just ask Hawaii Governor Josh ...

One person is in critical condition after a shooting early Saturday morning in the Far West side of Columbus. A police ...